The impact of COVID-19 on hepatitis C services

The impact of COVID-19 on hepatitis C services

Globally, the COVID-19 pandemic has led to significant, unprecedented changes to the delivery of healthcare and social services. There is a real concern that these changes in healthcare have led to delays in hepatitis C diagnosis, treatment and ongoing care, with potentially severe health consequences for people who have hepatitis C.

We will also explore what lessons we could learn from our response to COVID-19 to achieve our hepatitis C goals.

Moderator: Shriya Hari, COVID-19 Information Specialist and Education Coordinator, CATIE

Speakers:

• Dr. Naveed Janjua, Executive Director, Data and Analytic Services, B.C. Centre for Disease Control, Clinical Associate Professor, UBC School of Population & Public Health
• Dr. Brian Conway, Medical Director, Vancouver Infectious Diseases Centre
• Mia Biondi, Nurse Practitioner/Researcher, Viral Hepatitis Care Network/Toronto Centre for Liver Disease, University Health Network
• Leona Quewezance, Program Director, All Nations Hope
• Candace King, Peer Support Worker, North Lambton Community Health Centre

Register Here